We are live on
!
Find out more
KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
1-Year Est. Return
14.33%
This Fund
S&P 500
This Quarter
Est. Return
+8.41%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$256M
AUM Growth
–
Cap. Flow
+$249M
Cap. Flow
% of AUM
97.24%
Top 10 Holdings %
Top 10 Hldgs %
46.55%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$19.3M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$16.6M |
| 3 |
FNSR
Finisar Corp
FNSR
|
+$15.2M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$12.6M |
| 5 |
EMKR
Emcore Corp
EMKR
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.52% |
| 2 | Technology | 25.75% |
| 3 | Miscellaneous | 16.74% |
| 4 | Consumer Staples | 4.53% |
| 5 | Financials | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
American Express
AXP
$226B
| $968K | 0.38% |
+12,952
| New | +$921K |
|
|
SGNT
52
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $960K | 0.38% |
+45,763
| New | +$818K |
|
53
VF Corp
VFC
$5.36B
| $941K | 0.37% |
+20,709
| New | +$879K |
|
54
Verizon
VZ
$205B
| $933K | 0.36% |
+18,531
| New | +$946K |
|
55
3M
MMM
$92.2B
| $901K | 0.35% |
+9,850
| New | +$894K |
|
56
Aflac
AFL
$58.4B
| $896K | 0.35% |
+30,822
| New | +$836K |
|
57
Southwest Airlines
LUV
$19.5B
| $892K | 0.35% |
+69,171
| New | +$943K |
|
58
ExxonMobil
XOM
$643B
| $869K | 0.34% |
+9,619
| New | +$866K |
|
59
Marriott International
MAR
$92.3B
| $849K | 0.33% |
+21,019
| New | +$877K |
|
60
Vertex Pharmaceuticals
VRTX
$139B
| $848K | 0.33% |
+10,588
| New | +$780K |
|
|
NPSP
61
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $847K | 0.33% |
+56,045
| New | +$776K |
|
62
Eastman Chemical
EMN
$8.31B
| $838K | 0.33% |
+11,965
| New | +$834K |
|
63
AutoZone
AZO
$47.9B
| $837K | 0.33% |
+1,975
| New | +$806K |
|
|
ACHN
64
DELISTED
Achillion Pharmaceuticals
ACHN
| $837K | 0.33% |
+102,312
| New | +$781K |
|
65
Standard BioTools
LAB
$256M
| $836K | 0.33% |
+47,856
| New | +$840K |
|
66
PepsiCo
PEP
$191B
| $827K | 0.32% |
+10,108
| New | +$825K |
|
|
ELGX
67
DELISTED
Endologix Inc
ELGX
| $827K | 0.32% |
+6,226
| New | +$879K |
|
|
AMRN
68
Amarin Corp
AMRN
$297M
| $825K | 0.32% |
+7,110
| New | +$981K |
|
69
Align Technology
ALGN
$11.3B
| $818K | 0.32% |
+22,076
| New | +$761K |
|
70
Southern Company
SO
$102B
| $804K | 0.31% |
+18,212
| New | +$837K |
|
71
Cummins
CMI
$79B
| $797K | 0.31% |
+7,345
| New | +$833K |
|
72
State Street SPDR S&P 500 ETF Trust
SPY
$827B
| $786K | 0.31% |
+4,900
| New | +$789K |
|
|
MASI
73
DELISTED
Masimo
MASI
| $779K | 0.3% |
+36,764
| New | +$773K |
|
|
ONXX
74
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $778K | 0.3% |
+8,965
| New | +$825K |
|
75
IBM
IBM
$225B
| $775K | 0.3% |
+4,240
| New | +$826K |
|
Similar funds
OPPM
GX
PGA
SCG
TCMV
FCM
SAM
ACP
Kopp Investment Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Kopp Investment Advisors, which disclosed 93 positions worth $256M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is Array Biopharma Inc: 3,587,128 shares worth $16.3M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Technology and Miscellaneous.
- Kopp Investment Advisors's largest Q2 2013 buy was Array Biopharma Inc: 3,587,128 shares worth $16.3M.
- Kopp Investment Advisors's ten largest holdings make up 47% of its $256M portfolio in Q2 2013.
- Kopp Investment Advisors disclosed 93 positions in Q2 2013, its first 13F filing on record.
Based on Kopp Investment Advisors's 13F filing for Q2 2013, filed 5 Aug 2013.